Abbott Laboratories
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $9.41B | $18.62B | $5.00B | $4.06B | $3.48B | $10.80B | $6.81B | $3.65B |
| Accounts Receivable | $5.25B | $3.25B | $3.42B | $3.59B | $3.99B | $7.61B | $7.68B | $7.18B |
| Inventory | $3.60B | $2.43B | $2.60B | $2.64B | $2.69B | $3.79B | $3.28B | $3.19B |
| Total Current Assets | $20.15B | $26.78B | $14.16B | $13.56B | $19.25B | $31.32B | $23.77B | $22.32B |
| Property, Plant & Equipment | $7.61B | $5.71B | $5.73B | $5.94B | $5.91B | $8.06B | $7.87B | $7.97B |
| Goodwill | $24.02B | $7.68B | $9.64B | $10.07B | $9.77B | $15.77B | $15.71B | $15.93B |
| Intangible Assets (Excl. Goodwill) | $21.47B | $4.54B | $5.56B | $6.20B | $5.74B | $8.59B | $9.99B | $12.15B |
| Total Assets | $76.25B | $52.67B | $41.25B | $41.21B | $42.94B | $67.24B | $60.28B | $60.57B |
| Liabilities | ||||||||
| Accounts Payable | $2.40B | $1.18B | $1.08B | $1.06B | $1.03B | $1.80B | $1.72B | $1.54B |
| Total Current Liabilities | $8.91B | $6.66B | $9.19B | $10.47B | $9.51B | $13.28B | $15.48B | $17.26B |
| Long-Term Debt | $27.21B | $20.68B | $5.87B | $3.39B | $3.39B | $18.09B | $12.04B | $12.52B |
| Total Liabilities | $45.35B | $32.13B | $20.04B | $19.68B | $17.77B | $40.51B | $35.84B | $37.90B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $23.98B | $25.57B | $25.76B | $22.87B | $21.98B | $24.15B | $20.91B | $19.22B |
| Total Stockholders' Equity | $30.90B | $20.54B | $21.21B | $21.53B | $25.17B | $26.72B | $24.44B | $22.68B |